No amenities in govt hosp to treat cancer

Vijayawada: An estimate of 58,072 people in Andhra Pradesh have had cancer in 2016 and nearly 30,000 people died due to some form of cancer in the same year. Despite the high incidence and mortality rate, there is not a single government hospital dedicated to treating cancer cases in AP.

While three government cancer hospitals were promised for Andhra in 2014 by the then health minister in Nellore, Kurnool and Vijayawada – none have materialised yet. Given this situation, it is learnt that the condition of cancer care units set up in government teaching hospitals in the state is not bright either.

While the Linear Accelerator machine is being used for radiation therapy everywhere in the world, including the majority of private hospitals in Andhra, the government hospitals are still using outdated cobalt-based machines for radiotherapy in Guntur, Kurnool, Visakhapatnam and Kakinada, according to official sources. These cobalt-based machines have been discarded from everywhere except in a few third world countries.

“There is a dire need for the establishment of a regional cancer hospital and research centre in the state, in the likes of MNJ Institute of Oncology Regional Cancer Centre of Hyderabad,” Dr MV Ramanamma, former Vice-Chancellor of NTR health university, Vijayawada and palliative care specialist said.

An institute where cancer treatment would be the pivotal point around which other departments are established to provide comprehensive treatment for free of cost would be a boon to the thousands of patients who shell out a fortune for the treatment at private hospitals, she added.

On the other hand, not a single post for Surgical Oncology or Medical Oncology has been established in the government hospitals across the AP since bifurcation. “Most of the posts are in Telangana and patients don’t have these essential services here. This also greatly affects the medical students, especially those studying Oncology as a speciality said a government doctor.

  • Related Posts

    Galgotia Outrage in AI Expo evokes SOS from Domestic MedTech Industry

    Chinese ‘Made in India’ Fakes brazening out with Impunity in Here too New Delhi: Chinese slur on AI Expo, thanks to Galgotia fiasco, has hit a raw nerve in domestic…

    Innovation & Biomedical Skill Centre (IBSC) is transforming Biomedical & Medical Device Workforce Scenario

    Landmark Industry-Academia Meet in AMTZ Visakhapatnam: Andhra Pradesh MedTech Zone (AMTZ), India’s leading MedTech ecosystem, hosted a landmark Industry–Academia Meet to commemorate eight transformative years of the Innovation and Biomedical…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Medical Negligence and Quackery Rampant: 9-Year-Old Dies from Wrong Injection, Pregnant Woman Succumbs to Quack Treatment, Raids Uncover Illegal Practices Across MP, Haryana, UP & Chhattisgarh

    Medical Negligence and Quackery Rampant: 9-Year-Old Dies from Wrong Injection, Pregnant Woman Succumbs to Quack Treatment, Raids Uncover Illegal Practices Across MP, Haryana, UP & Chhattisgarh

    Drug Diversion Epidemic Sweeps India: Absence of Track-and-Trace System, overly Codeine Allotments, and Regulatory Apathy Fuel Misuse of Narcotic Syrups and Tablets

    Drug Diversion Epidemic Sweeps India: Absence of Track-and-Trace System, overly Codeine Allotments, and Regulatory Apathy Fuel Misuse of Narcotic Syrups and Tablets

    Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

    Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

    TN, Karnataka, Rajasthan declare highest number of NSQs in January

    TN, Karnataka, Rajasthan declare highest number of NSQs in January

    Centre reorganises CDSCO Zone Baddi amid Drug Quality Concerns

    Centre reorganises CDSCO Zone Baddi amid Drug Quality Concerns

    CDSCO modifies norms for testing permissions to speed up drug approvals

    CDSCO modifies norms for testing permissions to speed up drug approvals